Is EMS-CHEMIE HOLDING (SWX:EMSN) Fully Priced After Half Year Earnings?

EMS-CHEMIE HOLDING earnings event and why it matters now

EMS-CHEMIE HOLDING (SWX:EMSN) is back in focus after reporting half year 2026 results. Sales were CHF 1,010.06 million, while net income reached CHF 258.29 million and earnings per share came in at CHF 11.04.

The latest half year earnings have arrived while EMS-CHEMIE HOLDING’s share price has been strong, with a 1-day share price return of 2.86% and a year to date share price return of 43.82%. Over the past year, the total shareholder return of 31.86% contrasts with a 5 year total shareholder return that is down 8.34%, suggesting that recent momentum has strengthened after a weaker longer term stretch.

Scan other resilient compounders with earnings support and recent share price strength by checking the hand-picked 616 high quality undiscovered gems that share some of EMS-CHEMIE HOLDING's quality traits.

Bulls point to EMS-CHEMIE HOLDING’s resilient earnings and strong recent share price, while bears focus on the weaker 5 year return and a price above analyst targets. Which side does the current valuation support?

Price-to-Earnings of 39x for EMS-CHEMIE HOLDING: Is it justified?

On the latest close at CHF 791, EMS-CHEMIE HOLDING is trading on a P/E of 39x, which sits well above several reference points and suggests a rich valuation compared to peers and fair value estimates.

The P/E ratio compares the current share price with earnings per share. For EMS-CHEMIE HOLDING, a 39x P/E means investors are currently paying CHF 39 for every CHF 1 of recent earnings. For a chemicals company with forecast earnings growth of 6.33% per year and revenue growth of 4% per year, this is a relatively high earnings multiple that assumes the quality of earnings and returns can justify a premium.

There are two clear comparison anchors. First, EMS-CHEMIE HOLDING is described as expensive versus the estimated fair P/E of 25.7x, which is a level the market could move towards if expectations cool. Second, the current 39x P/E is above the peer average of 23.3x and the wider European chemicals industry average of 18x. That is a sizeable step up in valuation for a business where earnings have declined by 4.1% per year over the past 5 years, even though recent growth of 2.7% and a 22.7% return on equity point to high quality profitability today.

For investors weighing this P/E premium, the key question is whether EMS-CHEMIE HOLDING's high quality earnings, strong return on equity and reliable 2.33% dividend are enough to support a valuation multiple that sits significantly above both peers and the estimated fair ratio. Explore the SWS fair ratio for EMS-CHEMIE HOLDING

Result: Preferred multiple of Price-to-Earnings of 39x (OVERVALUED)

However, EMS-CHEMIE HOLDING's premium P/E and share price above analyst targets could face pressure if earnings growth or its CHF 474.35m net income profile weakens.

Find out about the key risks to this EMS-CHEMIE HOLDING narrative.

Another view on EMS-CHEMIE HOLDING’s valuation

Alongside the 39x P/E, EMS-CHEMIE HOLDING also screens as expensive on our DCF model. At CHF 791, the stock trades above an estimated future cash flow value of CHF 672.37. That raises a simple question for investors: Is it worth paying this much upfront for quality and consistency?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out EMS-CHEMIE HOLDING for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 267 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

The mix of optimism and caution around EMS-CHEMIE HOLDING is clear, so now is a good time to review the numbers yourself and decide where you stand. To see what the market currently views as the key upsides, take a closer look at the 2 key rewards

Looking for more EMS-CHEMIE HOLDING style investment ideas?

If EMS-CHEMIE HOLDING has sharpened your focus on quality and valuation, do not stop here. Broaden your watchlist now or risk missing stronger risk reward setups.

• Target resilient compounding potential by scanning a 616 high quality undiscovered gems that may not yet be crowded but already show strong fundamentals.
• Prioritise capital protection by reviewing a 313 resilient stocks with low risk scores that focuses on companies with sturdier risk profiles.
• Strengthen your core holdings by using a list of solid balance sheet and fundamentals (427 results) that keeps financial robustness at the forefront.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com